Nanoscale insights to improve organic solar cell thin films
A large international team has provided an understanding of how nanoscale interactions affect the thermal stability of a type of next generation organic solar cells.
Showing 901 - 920 of 1123 results
A large international team has provided an understanding of how nanoscale interactions affect the thermal stability of a type of next generation organic solar cells.
Three ANSTO staff members were involved in a chemical spill this morning when approx 250mL of sodium hydroxide was released from a pipe.
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.
Researchers use Kitaev theoretical model to explain unusual phenomenon in two-dimensional material.
Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.
The complex engineering of scientific instruments is explored in this 'behind the scenes' look at the installation of frontends for two new beamlines at the Australian Synchrotron.
ANSTO’s Innovation Precinct has been highlighted in the Greater Sydney Commission’s South District Plan.
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
Work with our scientists to deliver the best possible decommissioning outcome for your organisation.
Research highlights how biodistribution of a toxic substance essential to understand all exposure risks.
Lutetium-177 used for advanced prostate cancer
Modified component of green tea promises potential neuroblastoma treatment.